sb 239063 has been researched along with ml 3403 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
| Becker, C; Carrillo García, C; Fleischmann, BK; Forster, M; Freitag, P; Hesse, M; Laufer, S; Lohmann, S; Schade, D; Sievers, S | 1 |
2 other study(ies) available for sb 239063 and ml 3403
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
High-Throughput Screening Platform in Postnatal Heart Cells and Chemical Probe Toolbox to Assess Cardiomyocyte Proliferation.
Topics: Animals; Animals, Newborn; Cell Cycle; Cell Proliferation; Heart; High-Throughput Screening Assays; Mice; Mice, Inbred C57BL; Mitosis; Molecular Probes; Myocytes, Cardiac; Protein Kinase Inhibitors; Rats | 2022 |